Because the TNF-α pathway plays a critical role in tumor surveillance, there is concern that inhibition of this pathway could predispose patients to certain malignancies.
C. Andrew Kistler, MD, PharmD
Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.
